Poole Robert Michael 4
4 · Ovid Therapeutics Inc. · Filed Feb 4, 2022
Insider Transaction Report
Form 4
Poole Robert Michael
Director
Transactions
- Award
Stock Option (Right to Buy)
2022-02-03+15,000→ 15,000 totalExercise: $2.72Exp: 2032-02-03→ Common Stock (15,000 underlying)
Footnotes (1)
- [F1]The option will vest in full on February 3, 2023 subject to the Reporting Person's continuous service through such vesting date.